Last reviewed · How we verify
Lacosamide Tablets
At a glance
| Generic name | Lacosamide Tablets |
|---|---|
| Sponsor | Overseas Pharmaceuticals, Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Evaluation of the Efficacy, Safety, and Tolerability of Lacosamide in Major Depressive Episodes of Bipolar Disorder Types I and II. (PHASE3)
- Combined Effect of Pregabalin and Oxycodone, and Lacosamide and Oxycodone, on Breathing (PHASE4)
- Lacosamide Versus Propranolol in Migraine (PHASE3)
- A Trial to Investigate the Safety, Tolerability and Pharmacokinetics of Intravenous SPM 927 (PHASE2)
- A Multi-Centre, Randomized, Double-Blind, Placebo Controlled Pilot Trial to Assess the Efficacy, Safety, and Tolerability of SPM 927 in Subjects With Postherpetic Neuralgia (PHN). (PHASE2)
- A Trial to Assess the Efficacy and Safety of 400mg/Day Lacosamide in Subjects With Painful Diabetic Neuropathy (PHASE3)
- The Lacosamide's Effect on Calcitonin Gene-related Peptide in Migraine Patients (PHASE3)
- An Open-label follow-on Trial to Assess the Long-term Safety and Efficacy of Oral SPM 927 in Subjects With Diabetic Neuropathy (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Lacosamide Tablets CI brief — competitive landscape report
- Lacosamide Tablets updates RSS · CI watch RSS
- Overseas Pharmaceuticals, Ltd. portfolio CI